Oncologix Tech Inc. Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Oncologix Tech Inc.  (OCLG)

OCLG's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Aug 31 2014)
2014		 (Aug 31 2013)
2013		 (Aug 31 2012)
2012

Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

OCLG all Ratios >> Back to OCLG Management Effectiveness >> See Quarterly OCLG Return On Equity

You need to upgrade your Flash Player


Roe Comment
Despite detoriation in net income, company improved ROE to in (Aug 31 2014), company improved ROE to 197.38 % compare to previous year.


Financial Statements
Oncologix Tech's Equity $ -1 Millions Annual OCLG's Balance sheet
Oncologix Tech's Annual Income $ -1 Millions Annual OCLG's Income Statement
Where are OCLG's Income coming from? Visit OCLG's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.